BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34301485)

  • 1. Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals.
    Kiyasu Y; Takeuchi Y; Akashi Y; Kato D; Kuwahara M; Muramatsu S; Notake S; Ueda A; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2021 Oct; 27(10):1489-1492. PubMed ID: 34301485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan.
    Takeuchi Y; Akashi Y; Kato D; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2021 Jun; 27(6):890-894. PubMed ID: 33727026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective evaluation of diagnostic performance of a combo rapid antigen test QuickNavi-Flu+COVID19 Ag.
    Takeuchi Y; Akashi Y; Kiyasu Y; Terada N; Kurihara Y; Kato D; Miyazawa T; Muramatsu S; Shinohara Y; Ueda A; Notake S; Nakamura K; Suzuki H
    J Infect Chemother; 2022 Jun; 28(6):840-843. PubMed ID: 35277343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2.
    Akashi Y; Kiyasu Y; Takeuchi Y; Kato D; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2022 Feb; 28(2):248-251. PubMed ID: 34799237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
    Boum Y; Fai KN; Nikolay B; Mboringong AB; Bebell LM; Ndifon M; Abbah A; Essaka R; Eteki L; Luquero F; Langendorf C; Mbarga NF; Essomba RG; Buri BD; Corine TM; Kameni BT; Mandeng N; Fanne M; Bisseck AZ; Ndongmo CB; Eyangoh S; Hamadou A; Ouamba JP; Koku MT; Njouom R; Claire OM; Esso L; Epée E; Mballa GAE
    Lancet Infect Dis; 2021 Aug; 21(8):1089-1096. PubMed ID: 33773618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples.
    Akashi Y; Horie M; Takeuchi Y; Togashi K; Adachi Y; Ueda A; Notake S; Nakamura K; Terada N; Kurihara Y; Kiyasu Y; Suzuki H
    J Infect Chemother; 2022 Jun; 28(6):780-785. PubMed ID: 35256268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.
    Ngo Nsoga MT; Kronig I; Perez Rodriguez FJ; Sattonnet-Roche P; Da Silva D; Helbling J; Sacks JA; de Vos M; Boehm E; Gayet-Ageron A; Berger A; Jacquerioz-Bausch F; Chappuis F; Kaiser L; Schibler M; Renzoni A; Eckerle I
    PLoS One; 2021; 16(6):e0253321. PubMed ID: 34166410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2.
    Thell R; Kallab V; Weinhappel W; Mueckstein W; Heschl L; Heschl M; Korsatko S; Toedling F; Blaschke A; Herzog T; Klicpera A; Koeller C; Haugk M; Kreil A; Spiel A; Kreuzer P; Krause R; Sebesta C; Winkler S; Laky B; Szell M
    PLoS One; 2021; 16(11):e0259527. PubMed ID: 34843505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
    Torres I; Poujois S; Albert E; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Apr; 27(4):636.e1-636.e4. PubMed ID: 33421573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.
    Jakobsen KK; Jensen JS; Todsen T; Tolsgaard MG; Kirkby N; Lippert F; Vangsted AM; Martel CJ; Klokker M; von Buchwald C
    Dan Med J; 2021 Jun; 68(7):. PubMed ID: 34169830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant.
    Suzuki H; Akashi Y; Kato D; Takeuchi Y; Kiyasu Y; Terada N; Kurihara Y; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K
    J Infect Chemother; 2023 Mar; 29(3):257-262. PubMed ID: 36417995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Mboumba Bouassa RS; Veyer D; Péré H; Bélec L
    Int J Infect Dis; 2021 May; 106():8-12. PubMed ID: 33746093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France.
    Fitoussi F; Tonen-Wolyec S; Awaida N; Dupont R; Bélec L
    Infection; 2022 Jun; 50(3):625-633. PubMed ID: 34689310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale SARS-CoV-2 Antigen Testing With Real-World Specimens.
    Parikh A; Cooper L; Frogel D; Le Benger K; Cooper CK; Parvu V
    Front Public Health; 2022; 10():836328. PubMed ID: 35450121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott Panbio
    Shaw JLV; Deslandes V; Smith J; Desjardins M
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children.
    Drain P; Sulaiman R; Hoppers M; Lindner NM; Lawson V; Ellis JE
    Am J Clin Pathol; 2022 Apr; 157(4):602-607. PubMed ID: 34668536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.